SCHEMBL3393280

SCHEMBL3393280

CC(=O)Nc1cccc(-c2cc(C(N)=O)c3[nH]nc(C4CCNCC4)c3c2)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IKBKB O14920 2/20 0.47
CHUK O15111 2/20 0.47
JAK2 O60674 2/20 0.47
BTK Q06187 2/20 0.47
AAK1 Q2M2I8 2/20 0.45
CHEK1 O14757 3/20 0.43
FGFR1 P11362 1/20 0.43
NEK2 P51955 1/20 0.43
MAPK15 Q8TD08 1/20 0.43
PARP1 P09874 1/20 0.43
DHODH Q02127 1/20 0.43
USP30 Q70CQ3 1/20 0.41
PI4K2A Q9BTU6 1/20 0.41
NTRK1 P04629 1/20 0.41
MAP4K4 O95819 1/20 0.40
KIT P10721 1/20 0.40
DYRK1A Q13627 2/20 0.40
DYRK1B Q9Y463 2/20 0.40
MAPT P10636 1/20 0.39
JAK3 P52333 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3395796 0.90 IKBKB (0.47) IKBKBCHUKJAK2BTKPARP1
SCHEMBL3391160 0.87 CHUK (0.48) IKBKBCHUKBTKAAK1
SCHEMBL27698220 0.86 IKBKB (0.45) IKBKBCHUKJAK2BTKCHEK1
SCHEMBL3391461 0.84 IKBKB (0.64) IKBKBCHUKBTKCSF1R
SCHEMBL14365537 0.84 BTK (0.49) IKBKBCHUKJAK2BTKAAK1
SCHEMBL3391348 0.84 IKBKB (0.51) IKBKBCHUKBTKCHEK1PARP1
SCHEMBL3393228 0.83 JAK2 (0.46) JAK2BTKAAK1PARP1USP30
Hydrochloric Acid SCHEMBL3395054 0.83 IKBKB (0.63) IKBKBCHUKBTKCSF1R
SCHEMBL3393266 0.80 MKNK1 (0.53) IKBKBCHUKBTKCHEK1DYRK1A
SCHEMBL3395738 0.79 BTK (0.43) IKBKBCHUKJAK2BTKAAK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8501780-B2 Indazole carboxamides and their use GLAXOSMITHKLINE LLC (US) 2013-08-06 US disclosed
US-8501780-B2 Indazole carboxamides and their use GLAXOSMITHKLINE LLC (US) 2013-08-06 US disclosed
US-8501780-B2 Indazole carboxamides and their use GLAXOSMITHKLINE LLC (US) 2013-08-06 US disclosed
EP-1758578-B1 NOVEL INDAZOLE CARBOXAMIDES AND THEIR USE GLAXOSMITHKLINE LLC (US) 2010-12-29 EP disclosed
EP-1758578-B1 NOVEL INDAZOLE CARBOXAMIDES AND THEIR USE GLAXOSMITHKLINE LLC (US) 2010-12-29 EP disclosed
EP-1758578-A4 NOVEL INDAZOLE CARBOXAMIDES AND THEIR USE SMITHKLINE BEECHAM CORP (US) 2009-05-27 EP disclosed
US-20070281933-A1 Novel Indazole Carboxamides And Their Use SMITHKLINE BEECHAM CORPORATION (US) 2007-12-06 US disclosed
US-20070281933-A1 Novel Indazole Carboxamides And Their Use SMITHKLINE BEECHAM CORPORATION (US) 2007-12-06 US disclosed
US-20070281933-A1 Novel Indazole Carboxamides And Their Use SMITHKLINE BEECHAM CORPORATION (US) 2007-12-06 US disclosed
CN-101005836-A Novel indazole carboxamides and their use SMITHKLINE BEECHAM CORP (US) 2007-07-25 CN disclosed
EP-1758578-A2 NOVEL INDAZOLE CARBOXAMIDES AND THEIR USE Smithkline Beecham Corporation (US) 2007-03-07 EP disclosed
WO-2006002434-A2 NOVEL INDAZOLE CARBOXAMIDES AND THEIR USE SMITHKLINE BEECHAM CORPORATION (US) 2006-01-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070281933-A1 Novel Indazole Carboxamides And Their Use IKBKG, IRAK2, NFKBIA IKBKB 8/4885CHUK 9/4885JAK2 171/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.